| Posterprogramme |
| P 1 |
New substrates of CYP106A2 from Bacillus megaterium ATCC13368
S. Bleif, Saarland University, Saarbrücken/D; J.P. von Kries, M. Lisurek, Leibniz-Institut für Molekulare Pharmakologie (FMP), Berlin/D; F. Hannemann, R. Bernhardt, Saarland University, Saarbrücken/D |
| P 2 |
Abietane diterpenoids from the roots of Peltodon longipes with cytotoxic activity and inhibitory activity towards p38 alpha MAPK
M. Fronza, University of Freiburg/D; M. Goettert, University of Tübingen/D; R. Murillo, University of Costa Rica, San José/CR; S. Laufer, University of Tübingen/D; I. Merfort, University of Freiburg/D |
| P 3 |
Characterization of N-terminal substitutions in Glucagon-like Peptide 2
A. Klussmeier, S. Bandholtz, B. Wiedenmann, C. Groetzinger, Charité - Universitätsmedizin Berlin/D |
| P 4 |
New neurotensin(5-13) variants and insights in human neurotensin(5-13) and human neurotensin receptor 1 interactions
S. Bandholtz, Charité - Universitätsmedizin Berlin/D; J. Wichard, R. Kühne, Leibniz-Institut für Molekulare Pharmakologie (FMP), Berlin/D; B. Wiedenmann, C. Grötzinger, Charité - Universitätsmedizin Berlin/D |
| P 5 |
Phytochemical and biological investigation on the ethanolic extract of Cordia americana
F. Geller, M. Göttert, University of Tübingen/D; M. Fronza, C. Schmidt, University of Freiburg/D; V. Schattel, University of Tübingen/D; B. Heinzmann, E. Flores, University of Santa Maria/BR; I. Merfort, University of Freiburg/D; S. Laufer, University of Tübingen/D |
| P 6 |
Small-molecule inhibitors of the polo-box domain of polo-like kinase 1
W. Reindl, Max Planck Institute of Biochemistry, Martinsried/D; J. Yuan, A. Krämer, K. Strebhardt, University of Frankfurt/D; T. Berg, University of Leipzig/D |
| P 7 |
Synthesis of fluorescence labeled probes for sialyltransferase FP assays
J. Preidl, M. Lisurek, J. Rademann, Leibniz-Institut für Molekulare Pharmakologie (FMP), Berlin/D |
| P 8 |
Targeting signal transduction cascades in disease by novel small molecule nucleo-cytoplasmic transport inhibitors
V. Fetz, S.K. Knauer, University of Mainz/D; J.P. von Kries, J. Rademann, Leibniz-Institut für Molekulare Pharmakologie (FMP), Berlin/D; R.H. Stauber, University of Mainz/D |
| P 9 |
Searching for compounds inhibiting interleukin 8 gene expression
M. Reboll, Helmholtz Center for Infection Research, Braunschweig/D; M. Bartels, B. Ritter, Medical School Hannover/D; F. Sasse, R. Frank, Helmholtz Center for Infection Research, Braunschweig/D; M. Nourbakhsh, Translational Genomics Research Institute, Phoenix/USA |
| P 10 |
Stereoselective synthesis of bioactive 2-Aza-Analogs of the ipecac alkaloids
M. Kölzer, University of Hamburg/D; H.U. Göringer, M. Brecht, TU Darmstadt/D; T. Opatz, University of Hamburg/D |
| P 11 |
Viral channel proteins: from structure to drug development
W.B. Fischer, National Yang-Ming University, Taipei/RCCancelled by the author |
| P 12 |
Capture Compound Mass Spectrometry (CCMS) - a novel tool for functional proteomics and drug safety analysis
M. Sefkow, C. Blex, C. Dalhoff, M. Dreger, J. Fischer, M. Glinski, O. Graebner, F. Kroll, T. Lenz, Y. Luo, S. Michaelis, H. Koester, caprotec bioanalytics GmbH, Berlin/D |
| P 13 |
Fungal natural products as lead structures for the treatment of chronic inflammatory diseases and cancer
G. Erkel, A. Serwe, M. Jung, H. Belahmer, T. Anke, Institute of Biotechnology and Drug Research (IBWF e.V.), Kaiserslautern/D |
| P 14 |
Carboxylic acid isosteres linked to a carbazolic scaffold as gamma-secretase modulators
B. Schmidt, A. Zall, D. Kieser, N. Hoettecke, TU Darmstadt/D; K. Baumann, Roche Pharma AG, Basel/CH |
| P 15 |
Bioprofiling of small molecules by high content analysis
R. Diestel, F. Sasse, R. Frank, Helmholtz Center for Infection Research, Braunschweig/D |
| P 16 |
Synthesis of peptide-polymer conjugates for the investigation of peptide-protein interactions
K. Koschek, M. Dathe, J. Rademann, Leibniz-Institut für Molekulare Pharmakologie (FMP), Berlin/D |
| P 17 |
The influence of active Nrf2 on eNOS function and bioavailability of NO
E.H. Heiss, D. Schachner, V.M. Dirsch, University of Vienna/A |
| P 18 |
Identification, synthesis and characterisation of natural products with antiproliferative activity on HCC tumor cells
H. Eickhoff, A.-P. Schaffner, EMC microcollections GmbH, Tübingen/D; S. Venturelli, M. Bitzer, Medical University Hospital, Tübingen/D; K.-H. Wiesmüller, EMC microcollections GmbH, Tübingen/D |
| P 19 |
Inhibition of Eimeria tenella CDK-related kinase 2: from target identification to lead compounds
K. Engels, Intervet Innovation GmbH, Schwabenheim/D; C. Beyer, BASF SE, Ludwigshafen/D; M.L. Suarez Fernandez, F. Bender, M. Gaßel, R.J. Marhöfer, Intervet Innovation GmbH, Schwabenheim/D; J.C. Mottram, University of Glasgow/UK; G. Unden, University of Mainz/D; P.M. Selzer, Intervet Innovation GmbH, Schwabenheim/D |
| P 20 |
Inhibition of Eimeria tenella CDK-related kinase 2: bioinformatic analysis and biochemical characterization
M.L. Suarez Fernandez, K. Engels, F. Bender, M. Gaßel, R.J. Marhöfer, Intervet Innovation GmbH, Schwabenheim/D; G. Unden, University of Mainz/D; J.C. Mottram, University of Glasgow/UK; P.M. Selzer, Intervet Innovation GmbH, Schwabenheim/D |
| P 21 |
Virtual screening by high-throughput docking using hydrogen bonding constraints for targeting a protein-protein interface in M. tuberculosis
O. Koch, Intervet Innovation GmbH, Schwabenheim/D; K. Heller, L. Flohe, T. Jäger, Molisa GmbH, Magdeburg/D; P.M. Selzer, Intervet Innovation GmbH, Schwabenheim/D |
| P 22 |
Combinatorial synthesis of natural product - based pyrazolopyridine derivatives
K. Kaczanowska, University of Tübingen/D; A.-P. Schaffner, H. Eickhoff, K.-H. Wiesmueller, EMC microcollections GmbH, Tübingen/D |
| P 23 |
Mass spectrometric detection of human immunoreactive small chemicals
L. Dietz, S. Ohnesorge, University of Heidelberg, Mannheim/D; P. Pankert, Thermo Fisher Scientific, Inc, Darmstadt/D; S. Eikelmeier, University of Heidelberg, Mannheim/D; M. Schnoelzer, German Cancer Research Center, Heidelberg/D; H.-J. Thierse, University of Heidelberg, Mannheim/D |
| P 24 |
OCHEM - Online chemical modeling environment
R. Körner, I. Sushko, S. Novotarskyi, M. Rupp, A.K. Pandey, I.V. Tetko, Helmholtz Center Munich - National Research Center for Environment and Health, GmbH, Neuherberg/DCancelled by the author |
| P 25 |
Super-specific DNA methylation by targeting a methyltransferase with a covalently attached triple helix-forming oligonucleotide
A. Monami, M. Maluszynska-Hoffman, M. Bahr, RWTH Aachen/D; A. Kiss, BRC Szeged, Szeged/H; R. Wasserkort, Epigenomics AG, Berlin/D; B. van der Gun, P. McLaughlin, M. Rots, M. Ruiters, University Medical Center, Groningen/NL; E. Weinhold, RWTH Aachen/D |
| P 26 |
Computational methods in drug development
A. Kolodzik, M. Rarey, Universität Hamburg/D |
| P 27 |
Identification of cyclohexapeptides as potential sialic acid binding ligands using mass spectrometry
F. Zwanziger, University of Tübingen/D; J. Bauer, K.-H. Wiesmüller, EMC microcollections GmbH, Tübingen/D; H. Rotering, Merckle Biotec GmbH, Ulm/D; M.W. Wolff, Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg/D; S. Laufer, University of Tübingen/D |
| P 28 |
Phosphoranes as linker reagents: synthesis of a sphingosine library via smooth CC-couplings on polymer support
A. Eldahshan, J. Rademann, Leibniz Institute for Molecular Pharmacology (FMP), Berlin/D |
|
